Tackling Inadequate Pharmaceutical Services in Africa: Options for Public Health Action

Crossmark: check for updates

Authors

  • Babatunde Omilola Public Health, Security and Nutrition Division, The African Development Bank Group, Avenue Joseph Anoma, 01 BP 1387 Abidjan 01, Côte d'Ivoire
  • N’doh A. Sanogo Public Health, Security and Nutrition Division, The African Development Bank Group, Avenue Joseph Anoma, 01 BP 1387 Abidjan 01, Côte d'Ivoire

DOI:

https://doi.org/10.17140/PHOJ-5-141

Keywords:

dentification. Limited financial and human resources

Abstract

The present document aims to present challenges and opportunities to support pharmaceutical industry in Africa. The proliferation of fake medicines in the continent is a major public health problem, with a global market worth roughly US $200 billion and sub-Saharan Africa accounts for around 42% of the world’s cases (21% for north African and the middle East).1,2 We will first discuss the challenges for the continent in the fight against counterfeit medicines and finally the challenges and opportunities to support pharmaceutical industry in Africa.

References

World Health Organization (WHO). A bitter pill to swallow: the problem of, and solutions to, Sub-Saharan Africa’s counterfeit pharmaceutical trade Web site. https://www.ghjournal.org/a-bitter-pill-to-swallow-the-problem-of-and-solutions-to-sub-saharan-africas-counterfeit-pharmaceutical-trade/. Accessed February 11, 2020.

Pheage T. Dying from lack of medicines: Encouraging local production, right policies the way out Web site. https://www. un.org/africarenewal/magazine/december-2016-march-2017/ dying-lack-medicines. Accessed February 11, 2020.

Caillet C. Challenges in tackling the issue of poor quality Submit your article to this journal | https://openventio.org/submit-manuscript/ Opinion | Volume 5 | Issue 1| Sanogo NA et al medicines Web site. http://www.malaria.com/featured/medicine-quality-issues. Accessed February 11, 2020.

Ajepe B. The opportunities and challenges for pharmaceutical supply chain in Nigeria/Africa. Clin Pharmacol Biopharm. 2015; 4(4): 55. doi: 10.4172/2167-065X.C1.012

Conway M, Holt T, Sabow A, Sun Y. Should sub-Saharan Africa make its own drugs? Web site. https://www.mckinsey.com/ industries/public-sector/our-insights/should-sub-saharan-africa-make-its-own-drugs. Accessed February 11, 2020.

Mudau S. Opportunities and challenges in Africa’s pharmaceutical industry Web site. https://rouseafrica.com/. Accessed February 11, 2020.

Downloads

Published

2020-04-30

How to Cite

Babatunde Omilola, & N’doh A. Sanogo. (2020). Tackling Inadequate Pharmaceutical Services in Africa: Options for Public Health Action. Public Health - Open Journal, 5(1), 17–19. https://doi.org/10.17140/PHOJ-5-141

Issue

Vol. 5 No. 1 (2020): Volume 5 Issue 1 2020

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All content published in Public Health - Open Journal (PHOJ) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.